Clinical response of newly diagnosed HIV seropositive & seronegative pulmonary tuberculosis patients with the RNTCP short course regimen in Pune, India

Indian Journal of Medical Research

Volumn 133, Issue 5, 2011, Pages 521-528

  Tripathy, S ^a   Anand, A ^a   Inamdar, V ^a   Manoj, M M ^b   Khillare, K M ^b   Datye, A S ^b   Iyer, R ^c   Kanoj, D M ^b   Thakar, M ^a   Kale, V ^a   Pereira, M ^a   Risbud, A R ^a  

^a NATIONAL AIDS RESEARCH INSTITUTE   (India)

^b Talera Municipal Hospital   (India)

^c Pimpri Chinchwad Municipal Corporation   (India)

Author keywords

Anti retroviral therapy; HIV; HIV TB; RNTCP; Seropositive; Sputum; Tuberculosis

Indexed keywords

ANTIRETROVIRUS AGENT; TUBERCULOSTATIC AGENT; ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; DEATH; DIRECTLY OBSERVED THERAPY; FEMALE; FOLLOW UP; HEALTH PROGRAM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INDIA; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; NONHUMAN; OUTPATIENT CARE; SHORT COURSE THERAPY; SPUTUM ANALYSIS; TREATMENT RESPONSE; TUBERCULOSIS CONTROL; COMPARATIVE STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; INFECTION CONTROL; METHODOLOGY; MIDDLE AGED; SERODIAGNOSIS; STATISTICS; TREATMENT OUTCOME; VIROLOGY;

ADULT; ANTITUBERCULAR AGENTS; COMMUNICABLE DISEASE CONTROL; DIRECTLY OBSERVED THERAPY; ENZYME-LINKED IMMUNOSORBENT ASSAY; ETHAMBUTOL; HIV SERONEGATIVITY; HIV SEROPOSITIVITY; HUMANS; INDIA; ISONIAZID; MIDDLE AGED; PYRAZINAMIDE; RIFAMPIN; TREATMENT OUTCOME; TUBERCULOSIS, PULMONARY;

EID: 79958053076     PISSN: 09715916     EISSN: 09715916     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. World Health Organization. Global, regional and country specific data for key indicators (Annex 2). In: Global Tuberculosis Control - WHO Report 2010. Geneva: WHO; 2010. p. 57-204.
2. Mohanty KC, Nair S, Sahasrabudhe T. Changing trend of HIV infection in patients with respiratory disease in Bombay since 1988. Indian J Tuberc 1994; 41: 147-150.
3. Mohanty KC, Basheer PMM. Changing trend of HIV infection and tuberculosis in a Bombay area since 1988. Indian J Tuberc 1995; 42: 117-120.
4. Solomon S, Anuradha S, Rajasekaran S. Trend of HIV infection in patients with pulmonary tuberculosis in south India. Tuber Lung Dis 1995; 76: 17-19.
5. Purohit SD, Gupta RC, Bhattara VK. Pulmonary tuberculosis and human immunodeficiency virus infection in Ajmer. Lung India 1996; 14: 113-120.
6. Samuel NM, Alamelu C, Jagannath K, Rajan B. Detection of HIV infection in pulmonary tuberculosis patients. J Indian Med Assoc 1996; 94: 331-333.
7. Paranjape RS, Tripathy SP, Menon PA, Mehendale SM, Khatavkar P, Joshi DR, et al. Increasing trend of HIV seroprevalence among pulmonary tuberculosis patients in Pune, India. Indian J Med Res 1997; 106: 207-211.
8. Gupta PR, Luhadia SK, Gupta SN, Joshi V. Tuberculosis in human immunodeficiency virus seropositives in Rajasthan. Indian J Tuberc 1998; 16: 147-149.
9. Banvaliker JN, Gupta R, Sharma DC, Goel MK, Kumari S. HIV seropositivity in hospitalized pulmonary tuberculosis patients in Delhi. Indian J Tuberc 1999; 44: 17-20.
10. Sharma SK, Saha PK, Dixit Y, Siddaramaiah NH, Seth P, Pande JN. HIV seropositivity among adult tuberculosis patients in Delhi. Indian J Chest Dis Allied Sci 2000; 42: 157-160.
11. Sharma SK, Aggarwal G, Saha PK, Sanjeev L, Sinha PK. Increasing HIV seropositivity among adult tuberculosis patients in Delhi. Indian J Med Res 2003; 117: 239-242.
12. Raizada N, Chauhan LS, Khera A, Sokhey J, Wares DF, Sahu S, et al. HIV seroprevalence among tuberculosis patients in India, 2006-2007. PLoS ONE 2008; 3: e2970.
13. Swaminathan S, Ramachandran R, Bhaskar R, Ramanathan U, Prabhakar R, Datta M. Risk of development of tuberculosis in HIV infected individuals in India. Int J Tuberc Lung Dis 2000; 4: 839-844.
14. Chacko S, John TJ, Babu PG, Jacob M, Kaur A, Mathai D. Clinical profile of AIDS in India: a review of 61 cases. J Assoc Physicians India 1995; 43: 535-538.
15. Central TB Division (Government of India). RNTCP case finding and treatment outcome performance, 1999 - 2010 (Chapter 5). In: TB India 2011, revised National TB Control Program Annual Status report. New Delhi: Central TB Division; 2011. p. 107-115.
16. National AIDS Control Organization. Current epidemiological situation of HIV/AIDS (Chapter 2). In: Department of AIDS Control, Ministry of Health and Family Welfare Annual Report 2009-2010. New Delhi: NACO; 2010. p. 4-6.
17. Tripathy S, Joshi DR, Mehendale SM, Menon P, Joshi AN, Ghorpade SV, et al. Sentinel surveillance for HIV infection in tuberculosis patients in India. Indian J Tuberc 2002; 49: 17-20.
18. Bhatia R. Laboratory diagnosis. In: Sharma SK, Mohan A, editors. In: Tuberculosis, 2nd ed. New Delhi: Jaypee Brothers Medical Publishers (P) Ltd.; 2009. p. 160-72.
19. Revised National Tuberculosis Control Programme: TB/HIV training manual for medical officers. Mumbai: Maharashtra State Tuberculosis Control Society; 2006.
20. Global tuberculosis control, surveillance, planning, financing. WHO report 2007, Geneva: World Health Organization (WHO/HTM/TB/2007.376); 2007.
21. Swaminathan S, Deivanayagam CN, Rajasekaran S, Venkatesan P, Padmapriyadarsini C, Menon PA, et al. Long term follow up of HIV infected patients with tuberculosis treated with 6 month intermittent short course chemotherapy. Natl Med J India 2008; 21: 3-8.
22. Swaminathan S, Narendran G, Venkatesan P, Iliayas S, Santhanakrishnan R, Menon PA, et al. Efficacy of a 6 vs. 9 month intermittent treatment regimen in HIV infected TB patients: a randomized clinical trial. Am J Respir Crit Care Med 2009; 181: 743-751.
23. Ackah AN, Coulibaly D, Digbeu H, Diallo K, Vetter KM, Coulibaly IM, et al. Response to treatment, mortality, and CD4 lymphocyte counts in HIV-infected persons with tuberculosis in Abidjan, Cote d'Ivoire. Lancet 1995; 345: 607-610.
24. Chaisson RE, Clermont HC, Holt EA, Cantave M, Johnson MP, Atkinson J, et al. Six month supervised intermittent tuberculosis therapy in Haitian patients with and without HIV infection. Am J Respir Crit Care Med 1996; 154: 1034-1038.
25. Kassim S, Sassan-Morokro M, Ackah A, Abouya LY, Digbeu H, Yesso G, et al. Two-year follow-up of persons with HIV-1- and HIV-2-associated pulmonary tuberculosis treated with short-course chemotherapy in West Africa. AIDS 1995; 9: 1185-1191.
26. Kennedy N, Berger L, Curram J, Fox R, Gutmann J, Kisyombe GM, et al. Randomized controlled trial of a drug regimen that includes ciprofloxacin for the treatment of pulmonary tuberculosis. Clin Infect Dis 1996; 22: 827-833.
27. Perriens JH, St Louis ME, Mukadi YB, Brown C, Prignot J, Pouthier F, et al. Pulmonary tuberculosis in HIV-infected patients in Zaire: a controlled trial of treatment for either 6 or 12 months. N Engl J Med 1995; 332: 779-784.
28. Sterling TR, Alwood K, Gachuhi R, Coggin W, Blazes D, Bishai WR, Chaisson RE. Relapse rates after short-course (6-month) treatment of tuberculosis in HIV-infected and uninfected persons. AIDS 1999; 13: 1899-1904.
29. World Health Organization. Recommendations at a glance (Chapter 12). In: Antiretroviral therapy for HIV infection in adults and adolescents - recommendations for a public health approach 2010 revision. Geneva: WHO; 2010. p. 20-23.
30. Nahid P, Gonzalez LC, Rudoy I, de Jong BC, Unger A, Kawamura LM, et al. Treatment Outcomes of Patients with HIV and Tuberculosis. Am J Respir Crit Care Med 2007; 175: 1199-1206.